Find verified Fingolimod API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Fingolimod for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Fingolimod API.
Alternate Names: Gilenya, fingolimodum
CAS No: 162359-55-9
PubChem CID: 107970
Mol Formula: C19H33NO2
Mol Weight: 307.5 g/mol
IUPAC Name: 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
API Description: Multiple sclerosis, or MS, is a devastating inflammatory disease that often progresses and causes severe neurological, physical, and cognitive effects. Fingolimod is a sphingosine 1-phosphate receptor modulator for the treatment of relapsing-remitting multiple sclerosis. It was developed by Novartis and initially approved by the FDA in 2010. Fingolimod was also studied for the treatment of COVID-19, the disease caused by infection with the SARS-CoV-2 virus.
